Seeking Alpha

Exelixis Inc. (EXEL)

()

News & PR
Market Currents

Buzz
Twitter: EXEL

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Sep 11 • Justin M. Hall • ALTH, ARIA, ARQL • 23 Comments
Wall Street Breakfast: Must-Know News
Jul 31 • SA Editor Rachael Granby • AAPL, AAUKY.PK, AEP • 14 Comments
'When There's Blood in the Streets', Buy Biotech Stocks
Oct 10, 2008 • Ohad Hammer • ALNY, ALTH, AMGN • 13 Comments
Cancer Stocks Hammered Once Again
Jun 26, 2007 • Alan Brochstein • ABPI, AFFY, AGEN • 7 Comments
9 Possible Pharma Deals for 2009
Jan 8 • Zacks.com • ACOR, AMGN, ARNA • 7 Comments
Micromet: More Reasons for Optimism
May 11 • Ohad Hammer • ARQL, EXEL, IBB • 7 Comments
Licensing Deal Is Imminent for ArQule
Oct 2, 2008 • Ohad Hammer • AMGN, ARQL, BMY • 6 Comments
Keryx: Another Beneficiary of the ASCO Effect
Jun 3 • Michael Becker • AEZS, EXEL, KERX • 5 Comments
Poniard Pharmaceuticals: Platinum Rediscovered (Part II)
Jun 24, 2008 • Ohad Hammer • CELG, EXEL, GSK • 5 Comments
15 Overvalued Small Caps from Russell 2000
Jul 8 • Value Expectations • ARM, BLDR, BMTI • 5 Comments
Exelixis: A Platform Company for Oncology
Sep 3, 2008 • Ohad Hammer • EXEL • 4 Comments
Breakout Stocks on Huge Volume: Three Option Trades
Jul 27 • Marco Hickey • ACFN, ALXN, ARBA • 4 Comments
Small Cap Stocks Battling Brain Cancer
Sep 7 • Mike Havrilla • ARKTF.PK, BMY, CLDX • 4 Comments
Exelixis Upgraded With Good Reason (EXEL)
Mar 29, 2006 • Travis Johnson • EXEL • 3 Comments
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007 • Alan Brochstein • ABPI, ACEL, AFFY • 3 Comments
Three Recent Biotech Activist Wins by Carl Icahn
Aug 31 • Michael Becker • ALKS, AMLN, AZN • 3 Comments
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Sep 20 • Justin M. Hall • AGN, ALTH, ARIA • 3 Comments
Top Biotech Picks for ASCO 2009 (Part II)
May 27 • Ohad Hammer • ARQL, CRGN, EXEL • 2 Comments
ImmunoCellular's Promising Brain Cancer Vaccine
Oct 28 • Mike Havrilla • AGEN, CLDX, EXEL • 2 Comments
Friday Options Recap
May 29 • Frederic Ruffy • BEAT, DELL, ELN • 2 Comments
Two Potential Mega Biotech Deals Fuel Industry Hopes
May 31 • The Burrill Report • AMGN, APPA, CLDX • 2 Comments
Top Biotech Picks for ASCO 2009 (Part I)
May 27 • Ohad Hammer • ARQL, CRGN, EXEL • 2 Comments
Cancer Stocks Slide Again
Jun 18, 2007 • Alan Brochstein • ABPI, ACEL, AFFY • 1 Comment

Exelixis Inc. (EXEL)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers